- Home
- Publications
- Publication Search
- Publication Details
Title
A Review of Treatment Options for Progressive Supranuclear Palsy
Authors
Keywords
Levodopa, CoQ10, Progressive Supranuclear Palsy, Rasagiline, Progressive Supranuclear Palsy
Journal
CNS DRUGS
Volume 30, Issue 7, Pages 629-636
Publisher
Springer Nature
Online
2016-05-25
DOI
10.1007/s40263-016-0347-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsy
- (2016) Laurène Leclair-Visonneau et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy
- (2016) Maria Stamelou et al. MOVEMENT DISORDERS
- Interventions in progressive supranuclear palsy
- (2016) Christos Koros et al. PARKINSONISM & RELATED DISORDERS
- Progressive supranuclear palsy: progression and survival
- (2015) Julieta E. Arena et al. JOURNAL OF NEUROLOGY
- Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy
- (2015) Marcello Moccia et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- From a single nucleotide polymorphism to tau pathology: Appoptosin is the missing link
- (2015) Gesine Respondek et al. MOVEMENT DISORDERS
- Therapeutic advances in multiple system atrophy and progressive supranuclear palsy
- (2015) Werner Poewe et al. MOVEMENT DISORDERS
- Appoptosin-Mediated Caspase Cleavage of Tau Contributes to Progressive Supranuclear Palsy Pathogenesis
- (2015) Yingjun Zhao et al. NEURON
- Bilateral Pedunculopontine Nucleus Stimulation for Progressive Supranuclear Palsy
- (2015) Paresh K. Doshi et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
- (2014) Hong Xu et al. CURRENT GENE THERAPY
- Tau-Based Therapeutic Approaches for Alzheimer's Disease - A Mini-Review
- (2014) Allal Boutajangout et al. GERONTOLOGY
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases
- (2014) Giulietta Riboldi et al. MOLECULAR NEUROBIOLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
- (2014) Günter U. Höglinger et al. MOVEMENT DISORDERS
- The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases
- (2014) Gesine Respondek et al. MOVEMENT DISORDERS
- The use of botulinum toxin in the treatment of sialorrhea in parkinsonian disorders
- (2014) María T. Gómez-Caravaca et al. NEUROLOGICAL SCIENCES
- Atypical parkinsonism
- (2013) Maria Stamelou et al. CURRENT OPINION IN NEUROLOGY
- Brain homogenates from human tauopathies induce tau inclusions in mouse brain
- (2013) Florence Clavaguera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Appoptosin is a Novel Pro-Apoptotic Protein and Mediates Cell Death in Neurodegeneration
- (2012) H. Zhang et al. JOURNAL OF NEUROSCIENCE
- Clinicopathological study in progressive supranuclear palsy with pedunculopontine stimulation
- (2012) Lili-Naz Hazrati et al. MOVEMENT DISORDERS
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial Dysfunction as a Therapeutic Target in Progressive Supranuclear Palsy
- (2011) Vincent Ries et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
- (2011) Günter U Höglinger et al. NATURE GENETICS
- Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: Clinical observations as a basis for power calculations and safety analysis
- (2010) Iuga Liepelt et al. Alzheimers & Dementia
- Vaccination as a Therapeutic Approach to Alzheimer's Disease
- (2010) Thomas Wisniewski et al. MOUNT SINAI JOURNAL OF MEDICINE
- In vivo Evidence for Cerebral Depletion in High-Energy Phosphates in Progressive Supranuclear Palsy
- (2009) Maria Stamelou et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Nigrostriatal upregulation of 5-HT2Areceptors correlates with motor dysfunction in progressive supranuclear palsy
- (2009) Maria Stamelou et al. MOVEMENT DISORDERS
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study
- (2008) Gilbert Bensimon et al. BRAIN
- Short-term effects of coenzyme Q10 in progressive supranuclear palsy: A randomized, placebo-controlled trial
- (2008) Maria Stamelou et al. MOVEMENT DISORDERS
- Subthalamic stimulation improves levodopa responsive symptoms in a case of progressive supranuclear palsy
- (2007) Kenneth J. Bergmann et al. PARKINSONISM & RELATED DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now